Related Experiment Video
Updated: Jun 28, 2026
07:22
A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
1.4K
Achieving Steroid-Sparing Remission in Refractory Pyoderma Gangrenosum With an Integrative Meta-Therapeutic System
Magesh Kirubakaran J P1, Pooja Shrivastav1, Sangeetha R2,3
1Department of Shalya Tantra, Mahatma Gandhi Ayurveda College & Research Centre, Datta Meghe Institute of Higher Education & Research (Deemed to be University), Salod (H), Wardha, India.
Case Reports in Dermatological Medicine
|May 4, 2026
Summary
A novel integrative nanomedicine system effectively treated refractory pyoderma gangrenosum (PG). This treatment significantly reduced ulcer size and improved patient function, offering a steroid-sparing alternative for severe cases.
Area of Science:
- Integrative Nanomedicine
- Dermatology
- Immunomodulation
Background:
- Pyoderma gangrenosum (PG) management is challenging due to complex immunopathogenesis.
- Conventional therapies (steroids, biologics) are insufficient for treatment-refractory cases.
- A need exists for novel immune-modulating strategies.
Purpose of the Study:
- To evaluate an integrative meta-therapeutic system for refractory PG.
- To assess the efficacy of a nanostructured mercury sulfide (HgS) core combined with phytocompounds, glucocorticoids, and a supportive milieu.
Main Methods:
- A 30-day protocol using a nanostructured herbo-metallic core (Linga Chenduram), Allium sativum, Aloe vera, pulsed glucocorticoids, and an anti-inflammatory milieu.
- Treatment applied to four patients with PG refractory to conventional immunosuppressants.
- Clinical and functional outcomes assessed, including ulcer area, C-reactive protein, and Anterior Knee Pain Scale.
Main Results:
- Mean ulcer area reduction of over 61% by Day 30, with complete re-epithelialization in all patients.
- Normalization of systemic inflammation (C-reactive protein) and significant functional improvement (35-point increase on Anterior Knee Pain Scale).
- Clinical remission maintained for 6 months, demonstrating a steroid-sparing effect.
Conclusions:
- The integrative nanomedicine system demonstrated rapid and profound clinical response in refractory PG.
- Rational polypharmacology involving nanoengineered HgS may modulate immune pathways like NF-κB.
- This approach offers a paradigm for refractory autoinflammation and warrants further investigation of refined traditional nanomedicines.
